P-7 (13Therapeutics)

N/A

Report date: 2025/06/11 10:41:11

Base Information

Drug NameP-7 (13Therapeutics)
Drug Alias Nametoll-like receptor inhibitor (13Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionToll like receptor 4 inhibitorsToll like receptor 3 antagonists
TargetsToll like receptor 3Toll like receptor 4
Therapy Area/IndicationsInflammationHearing LossSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies13Therapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies13Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsHearing LossSepsis

Other Information

ATC CodeN/A
Related LinksN/A